|
| EboDrogueIn terms of Regulation 24 A of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations, 2015, we enclose Secretarial Compliance Report duly issued by N. http://www.paccp.ca/advert/zocon-150-tablets-vs-fdc-ltd-anti-fungal/ http://survivalswapmeet.com/advert/aziderm-cream-20-you-micro-labs-acne-skin-care/ http://pinkandblueparenting.com/advert/methanabol-10-mg-side-effects-phoenix-remedies-oral-steroids/ http://alnnetwork.com/advert/bi-mart-hours-today-la-pine-oregon-ajanta-pharma-eye-care http://advicks.com/advert/zolmist-nasal-spray-5-mg-keratin-cipla-pain-management/ 縺ゅ縺 メッセージ |
|